AI system could boost survival chances for sepsis patients

A newly-developed artificial intelligence (AI) system may be the answer for treating and preventing fatal outcomes for sepsis patients, according to a recent study.

An AI Clinician system matched or made better treatment decisions than human physicians 98 percent of the time, according to the study. Patient mortality was lowest when human doctors treatments matched the AI system’s suggestion. When physician’s decisions were different from the system, patients chances of survival were reduced.

“The AI Clinician was able to ‘learn’ from far more patients than any doctor could see in a lifetime. It has learnt from 100,000 patients and ‘remembered’ them all equally, whereas doctors are always susceptible to recall bias, where they particularly remember recent cases or unusual cases,” Anthony Gordon, MD, FRCA, FFICM, senior author of the study and Imperial College London professor, said in a statement.

The system’s abilities were detailed in a study conducted by researchers with the Imperial College London and published in Nature Medicine.

The AI Clinician system analyzed the medical records of 96,000 American patients with sepsis, a potentially fatal complication from a blood infection. By using reinforcement learning, the system was able to assess each patient’s case and decide the best strategies for keeping that patient alive.  

With the system proven to be a reliable treatment option for sepsis patients, researchers now hope to test its abilities in UK hospitals.

“The only way for any technology to help a patient is to turn it into a product that doctors and hospitals can prescribe, therefore we are seeking to [commercialize],” study author A. Aldo Faisal, PhD, said in a statement.

""

Danielle covers Clinical Innovation & Technology as a senior news writer for TriMed Media. Previously, she worked as a news reporter in northeast Missouri and earned a journalism degree from the University of Illinois at Urbana-Champaign. She's also a huge fan of the Chicago Cubs, Bears and Bulls. 

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”